|
Country
|
Number of responses
|
Number of pseudo-ICUs
|
Mean years of experience in critical care
|
Proportion female sex
|
Number of beds in ICU
|
Availability of VAP prevention standards
|
Existence of VAP surveillance system
|
VAP measure 1
|
VAP measure 2
|
VAP measure 3
|
VAP measure 4
|
VAP measure 5
|
VAP measure 6
|
Sum of VAP measures 1-6
|
|---|
|
AR
|
40
|
24
|
15.00
|
25%
|
13.20
|
65%
|
68%
|
100%
|
63%
|
73%
|
98%
|
78%
|
78%
|
4.88
|
|
AT
|
130
|
58
|
12.75
|
35%
|
8.97
|
40%
|
45%
|
96%
|
44%
|
47%
|
93%
|
98%
|
82%
|
4.59
|
|
AU
|
23
|
17
|
14.17
|
9%
|
19.43
|
30%
|
30%
|
100%
|
48%
|
39%
|
70%
|
100%
|
91%
|
4.48
|
|
BE
|
33
|
25
|
17.21
|
24%
|
21.15
|
73%
|
48%
|
100%
|
52%
|
91%
|
55%
|
97%
|
94%
|
4.88
|
|
BR
|
21
|
18
|
13.86
|
10%
|
20.71
|
81%
|
76%
|
100%
|
71%
|
86%
|
95%
|
62%
|
67%
|
4.81
|
|
CH
|
29
|
16
|
9.90
|
24%
|
12.93
|
69%
|
38%
|
97%
|
69%
|
72%
|
86%
|
86%
|
93%
|
5.03
|
|
CO
|
31
|
19
|
9.45
|
29%
|
14.84
|
68%
|
74%
|
97%
|
55%
|
84%
|
87%
|
77%
|
97%
|
4.97
|
|
DE
|
67
|
49
|
11.81
|
15%
|
22.93
|
67%
|
52%
|
97%
|
54%
|
60%
|
93%
|
99%
|
84%
|
4.85
|
|
ES
|
293
|
107
|
16.10
|
38%
|
15.80
|
81%
|
74%
|
98%
|
43%
|
94%
|
93%
|
93%
|
87%
|
5.09
|
|
FR
|
251
|
113
|
11.50
|
24%
|
14.88
|
47%
|
61%
|
96%
|
19%
|
55%
|
69%
|
90%
|
94%
|
4.24
|
|
GB
|
115
|
57
|
10.74
|
22%
|
17.16
|
79%
|
50%
|
98%
|
81%
|
90%
|
50%
|
87%
|
87%
|
4.92
|
|
GR
|
23
|
15
|
11.35
|
61%
|
11.00
|
30%
|
39%
|
96%
|
30%
|
83%
|
61%
|
52%
|
74%
|
3.96
|
|
IN
|
63
|
44
|
9.25
|
6%
|
23.94
|
81%
|
79%
|
100%
|
95%
|
90%
|
84%
|
81%
|
97%
|
5.48
|
|
IT
|
187
|
56
|
15.47
|
34%
|
8.34
|
60%
|
48%
|
91%
|
35%
|
76%
|
50%
|
70%
|
70%
|
3.93
|
|
MX
|
31
|
19
|
10.97
|
10%
|
10.16
|
52%
|
68%
|
97%
|
42%
|
39%
|
87%
|
90%
|
81%
|
4.35
|
|
NL
|
31
|
22
|
9.06
|
16%
|
20.87
|
81%
|
39%
|
81%
|
61%
|
35%
|
68%
|
84%
|
87%
|
4.16
|
|
PE
|
23
|
15
|
14.52
|
9%
|
12.96
|
43%
|
57%
|
96%
|
48%
|
4%
|
91%
|
78%
|
48%
|
3.65
|
|
PT
|
50
|
27
|
12.46
|
42%
|
12.18
|
58%
|
68%
|
100%
|
38%
|
80%
|
68%
|
78%
|
84%
|
4.48
|
- Availability of VAP prevention standards: country averages of positive responses to the question (yes/no): “In my ICU, we have written clinical guidelines for the prevention of ventilator-associated pneumonia”.
- Existence of VAP surveillance system: country averages of positive responses to the question (yes/no): “in my ICU, we count and record VAP on a routine basis”.
- VAP prevention measure 1: Head of bed elevation; VAP prevention measure 2: daily sedation and weaning protocol; VAP prevention measure 3: Oral care with chlorhexidine; VAP prevention measure 4: No ventilator circuit change unless indicated; VAP prevention measure 5: Cuff pressure control at lease every 24 hrs; VAP prevention measure 6: Strict hand hygiene using alcohol.
- Only countries with >20 responses are included in Table 1.
- Country appreviations: ES = SPAIN; FR = FRANCE; IT = ITALY; AT = AUSTRIA; GB = UNITED KINGDOM; DE = GERMANY; IN = INDIA; PT = PORTUGAL; AR = ARGENTINA; BE = BELGIUM; CO = COLOMBIA; MX = MEXICO; NL = NETHERLANDS; CH = SWITZERLAND; AU = AUSTRALIA; GR = GREECE; PE = PERU; BR = BRAZIL.
